Hospice Care
Hospice operators providing end-of-life comfort care to terminally ill patients in home, facility, and inpatient settings.
- 4
- Verticals
Overview
Hospice Care covers operators providing end-of-life comfort care to terminally ill patients in home, facility, and inpatient settings, funded primarily through the Medicare hospice benefit. Leaders include VITAS (Chemed), Amedisys, Compassus, and Gentiva, alongside a fragmented base of local providers.
The Medicare hospice benefit's favorable economics and the aging population have driven strong growth and heavy private-equity roll-up, though the sector has drawn regulatory and quality scrutiny (program integrity, especially in high-growth markets). It is recurring, per-diem, and reimbursement-driven.
Market snapshot
Within home health & hospice (NAICS 621610); the Census Bureau does not separate hospice, so it is not separately sized.
Business model & economics
Revenue model
Medicare hospice per-diem reimbursement
Key economics
- Recurring revenue
- High
- EBITDA margin
- Healthy under the Medicare hospice benefit
- Capex intensity
- Low
per-diem over length of care
Characteristics
- Funded primarily by the Medicare hospice benefit.
- Aging population and favorable economics drive growth.
- Program-integrity and quality scrutiny in high-growth markets.
M&A deal context
Who’s acquiring
- Hospice & home-care platforms
- PE-backed hospice consolidators
- Payer-aligned acquirers
What’s driving deals
- Heavy roll-up under the Medicare hospice benefit.
- Aging-population demand.
- Regulatory and quality scrutiny shaping deals.
Verticals in this segment
Find Hospice Care acquisition targets
Search Acquisera’s index for companies classified under Hospice Care (4.6.3) and build a targeted deal pipeline.
Search companies